- Investing Ideas
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
17
High return on equity, past performance and sound balance sheet.
17 companies
Sanofi Consumer Healthcare India
Market Cap: ₹108.8b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,724.10
7D
2.2%
1Y
-4.5%
ALTEOGEN
Market Cap: ₩19.9t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩371,500.00
7D
5.1%
1Y
-3.9%
Sanofi India
Market Cap: ₹82.4b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,578.55
7D
3.3%
1Y
-43.3%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹412.0b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,432.10
7D
0.9%
1Y
-13.6%
Abbott India
Market Cap: ₹543.5b
Operates as a pharmaceutical company in India.
500488
₹25,578.90
7D
-0.6%
1Y
-17.2%
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€94.80
7D
2.6%
1Y
26.5%
Highnoon Laboratories
Market Cap: PK₨54.5b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,028.48
7D
3.4%
1Y
10.6%
GlaxoSmithKline Pakistan
Market Cap: PK₨124.1b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨389.55
7D
10.0%
1Y
-14.8%
China Resources Jiangzhong PharmaceuticalLtd
Market Cap: CN¥17.1b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥27.22
7D
6.3%
1Y
18.5%
Exelixis
Market Cap: US$11.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$43.61
7D
-3.0%
1Y
22.5%
Consun Pharmaceutical Group
Market Cap: HK$13.5b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.00
7D
-3.0%
1Y
69.1%
DHG Pharmaceutical
Market Cap: ₫13.0t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫99,600.00
7D
-0.6%
1Y
1.7%
Rigel Pharmaceuticals
Market Cap: US$599.1m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$32.49
7D
8.4%
1Y
91.9%
Chugai Pharmaceutical
Market Cap: JP¥14.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,844.00
7D
3.0%
1Y
5.0%
Gubra
Market Cap: DKK 5.6b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 345.20
7D
4.0%
1Y
-3.0%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.3b
Engages in the pharmaceutical business in China.
000915
CN¥31.26
7D
1.0%
1Y
-0.4%
Blue Jet Healthcare
Market Cap: ₹71.5b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹412.35
7D
2.4%
1Y
-44.5%